Literature DB >> 26184363

MR Spectroscopy: A Longitudinal Biomarker for Substantia Nigra Pathology in Parkinson's Disease?

Gülin Öz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26184363      PMCID： PMC4558370          DOI： 10.1002/mds.26322

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  19 in total

1.  Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.

Authors:  C M Ellis; G Lemmens; S C Williams; A Simmons; J Dawson; P N Leigh; K R Chaudhuri
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

Review 2.  Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease.

Authors:  D J Brooks
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

Review 3.  Magnetic resonance imaging and spectroscopy in Parkinson's disease.

Authors:  W R Martin
Journal:  Adv Neurol       Date:  2001

4.  Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations.

Authors:  Gülin Oz; Melissa Terpstra; Ivan Tkác; Pratibha Aia; Jodi Lowary; Paul J Tuite; Rolf Gruetter
Journal:  Magn Reson Med       Date:  2006-02       Impact factor: 4.668

5.  Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.

Authors:  B A Holshouser; M Komu; H E Möller; J Zijlmans; H Kolem; D B Hinshaw; P Sonninen; P Vermathen; A Heerschap; H Masur
Journal:  Magn Reson Med       Date:  1995-05       Impact factor: 4.668

6.  Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy.

Authors:  B Y Choe; J W Park; K S Lee; B C Son; M C Kim; B S Kim; T S Suh; H K Lee; K S Shinn
Journal:  Invest Radiol       Date:  1998-08       Impact factor: 6.016

7.  T2 relaxation time in patients with Parkinson's disease.

Authors:  A Antonini; K L Leenders; D Meier; W H Oertel; P Boesiger; M Anliker
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

8.  Longitudinal study of the substantia nigra in Parkinson disease: A high-field (1) H-MR spectroscopy imaging study.

Authors:  Navid Seraji-Bozorgzad; Fen Bao; Edwin George; Shana Krstevska; Veronica Gorden; Jessica Chorostecki; Carla Santiago; Imad Zak; Christina Caon; Omar Khan
Journal:  Mov Disord       Date:  2015-07-31       Impact factor: 10.338

9.  Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.

Authors:  Hyun-Man Baik; Bo-Young Choe; Byung-Chul Son; Sin-Soo Jeun; Moon-Chan Kim; Kwang-Soo Lee; Bum-Soo Kim; Jae-Mun Lee; Hyoung-Koo Lee; Tae-Suk Suh
Journal:  Eur J Radiol       Date:  2003-09       Impact factor: 3.528

10.  Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.

Authors:  Joseph O'Neill; Norbert Schuff; William J Marks; Robert Feiwell; Michael J Aminoff; Michael W Weiner
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.